CARD9, a key regulator of caspase activation and NF-κB signaling, was abnormally upregulated in ovarian cancer tissues and cells, where its knockdown led to reduced cell proliferation and enhanced cisplatin sensitivity [72]. Here, NFKB1 is linked to ovarian carcinoma.